miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 5, 2025

$208 million wiped out: Yieldstreet investors rack up more losses as firm rebrands to Willow Wealth

View original at cnbc.com
$208 million wiped out: Yieldstreet investors rack up more losses as firm rebrands to Willow Wealth As Yieldstreet tries to distance itself from a rocky past with a new name and ad campaign, its customers are dealing with a present reality that is increasingly dire…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The property was unable to generate sufficient revenue to pay monthly debt service and operating expenses and went into foreclosure, resulting in a full loss of the equity

    80% confidence
  • This building was majority-owned by YieldStreet and the property was never operated either by Flow or anyone associated with Adam. The building has been sold and Flow no longer has a minority interest nor any involvement in this property.

    80% confidence
  • Portfolios including private markets have outperformed traditional ones for the past 20 years

    80% confidence
  • They claimed they were going to democratize access to the types of deals only the rich had. In reality, they created a high-risk trap for investors.

    80% confidence
  • Yieldstreet had to change their name because their old name had negative value to it, so they're trying to do a 2.0 to restart things

    80% confidence
  • Private investments would provide both higher returns and lower volatility than traditional assets

    80% confidence
  • Your equity investment is expected to incur a full loss after selling Stacks on Main

    80% confidence
  • Failures were caused by the Federal Reserve's interest rate hiking cycle in 2022, which made repaying floating-rate debt harder

    80% confidence
  • Transparency is paramount to us, and we consistently provide strategy-specific performance information for each manager at the offering level to support informed decision making

    80% confidence
  • CNBC's reporting on new real estate defaults and rising tally of losses is a rehash of news on investments from five years ago

    80% confidence
  • We understand this is difficult news to receive. We share in your disappointment.

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
$208 million wiped out: Yieldstreet investors rack up more losses as firm rebrands to Willow Wealth — Source | Via News | es.VIA.NEWS